Literature DB >> 16893736

Markers for sepsis diagnosis: what is useful?

Konrad Reinhart1, Michael Meisner, Frank M Brunkhorst.   

Abstract

Timely diagnosis of the different severities of septic inflammation is potentially lifesaving because therapies that have been shown to lower mortality should be initiated early. Sepsis and severe sepsis are accompanied by clinical and laboratory signs of systemic inflammation but patients with inflammation caused by noninfectious causes may present with similar signs and symptoms. It is important to identify markers for an early diagnosis of sepsis and organ dysfunction. This article presents currently interesting sepsis biomarkers. Other novel markers and their potential role are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893736     DOI: 10.1016/j.ccc.2006.03.003

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  40 in total

1.  Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis.

Authors:  Helena Brodská; Karin Malíčková; Václava Adámková; Hana Benáková; Markéta Marková Šťastná; Tomáš Zima
Journal:  Clin Exp Med       Date:  2012-05-27       Impact factor: 3.984

Review 2.  Sepsis: a clinical update.

Authors:  Corey E Ventetuolo; Mitchell M Levy
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-07       Impact factor: 8.237

3.  Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis.

Authors:  Jing Jiyong; Huang Tiancha; Cui Wei; Shen Huahao
Journal:  Intensive Care Med       Date:  2008-10-21       Impact factor: 17.440

Review 4.  Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.

Authors:  Kailash N Pandey
Journal:  Can J Physiol Pharmacol       Date:  2011-08-04       Impact factor: 2.273

Review 5.  Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis.

Authors:  H Tang; T Huang; J Jing; H Shen; W Cui
Journal:  Infection       Date:  2009-10-13       Impact factor: 3.553

Review 6.  The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigms.

Authors:  Kailash N Pandey
Journal:  FEBS J       Date:  2011-04-07       Impact factor: 5.542

Review 7.  De-escalating Antibiotic Use in the Inpatient Setting: Strategies, Controversies, and Challenges.

Authors:  J Daniel Markley; Shaina Bernard; Gonzalo Bearman; Michael P Stevens
Journal:  Curr Infect Dis Rep       Date:  2017-04       Impact factor: 3.725

8.  Diagnostic value of soluble CD14 subtype (sCD14-ST) presepsin for the postmortem diagnosis of sepsis-related fatalities.

Authors:  Cristian Palmiere; Michele Mussap; Daniel Bardy; Francesco Cibecchini; Patrice Mangin
Journal:  Int J Legal Med       Date:  2012-12-22       Impact factor: 2.686

9.  Diagnostic value of lipopolysaccharide-binding protein and procalcitonin for sepsis diagnosis in forensic pathology.

Authors:  Marc Augsburger; Katia Iglesias; Daniel Bardy; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2012-10-13       Impact factor: 2.686

10.  Microalbuminuria: A novel biomarker of sepsis.

Authors:  Surupa Basu; Mahuya Bhattacharya; Tapan K Chatterjee; Subimal Chaudhuri; Subhash K Todi; Arghya Majumdar
Journal:  Indian J Crit Care Med       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.